The CLHIA has called on the Ontario government to recognize the Harmonized Life License Qualification Program when setti…

Review Board sets out on 30-day public consultations on draft pricing guidelines for medicines.

High-cost, specialty medicines account for an ever-increasing proportion of new treatments coming to market, reveals a n…

New medicines simply won’t be coming to Canada if the government goes ahead with changes to how the Patented Medicines P…

A new report by the Patented Medicine Prices Review Board (PMPRB) reveals that prescription drug expenditures by Canadia…

The federal government announced today the final amendments to the Patented Medicines Regulations which it says will red…

Nearly all of the new medicines entering the market in recent years came with high treatment costs, says a new report by…